Charlotte Dunbar
Eli Lilly (United Kingdom)(GB)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Neuroscience and Neuropharmacology Research, Computational Drug Discovery Methods, Autophagy in Disease and Therapy, Cellular transport and secretion
Most-Cited Works
- → FE65 interacts with ADP‐ribosylation factor 6 to promote neurite outgrowth(2013)35 cited
- → A human tau seeded neuronal cell model recapitulates molecular responses associated with Alzheimer’s disease(2022)14 cited
- → Discovery of N-methylpiperazinyl flavones as a novel class of compounds with therapeutic potential against Alzheimer’s disease: synthesis, binding affinity towards amyloid β oligomers (Aβo) and ability to disrupt Aβo-PrPC interactions(2019)13 cited
- → Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting Aβo–PrPCbinding and downstream pathways(2021)9 cited
- → [P4–102]: CHARACTERISATION OF MOLECULAR MECHANISMS THAT ARE TRIGGERED AND CONTRIBUTE TO TAU PATHOLOGY IN A CELL MODEL OF TAU AGGREGATION(2017)
- Fe65-amyloid precursor protein signalling and Alzheimer's disease(2017)
- [Postcard to Ms. Charlotte Dunbar, December 1, 1917](1917)